IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Arvee Laboratories (India) IPO is a Fixed Price listing on NSE EMERGE exchange, with an ipo size of ₹ 8.91 Cr. The company is based in Ahmedabad and caters to Chemical - Speciality sector. Sarthi Capital Advisors is the merchant banker of Arvee Laboratories (India) IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 21st December 2017.
Arvee Laboratories (India) IPO posted revenues of ₹ 39.60 crores and PAT of ₹ 0.64 crores in FY18 on annualised basis.
Revenue:
₹ 39.28 Cr.
EBITDA Margin:
15.89
% 
Net Worth: ₹ 4.48 Cr.
Market Capitalisation:
[●]
P/E:
52.00 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Arvee Laboratories (India) IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-17 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 39.17 | 35.67 | 35.20 | 26.02 | |
| Net Worth | 4.48 | 4.19 | 2.64 | 1.41 | |
| Total Debt | 24.04 | 23.79 | 23.65 | 20.78 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
19.64
39.28 |
34.42 | 26.82 | 12.96 | |
EBITDA
EBITDA on annualised basis |
3.12
6.24 |
6.39 | 5.08 | 2.17 | |
PAT
PAT on annualised basis |
0.31
0.62 |
1.55 | 0.18 | -1.64 | |
Arvee Laboratories (India) IPO PAT Margin is 1.58 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Arvee Laboratories (India) IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-17 | FY17 | FY16 | FY15 |
|---|---|---|---|---|
| EBITDA Margin (%) | 15.89 | 18.56 | 18.94 | 16.74 |
| PAT Margin (%) | 1.58 | 4.50 | 0.67 | -12.65 |
| EPS (₹) | 0.78 | 3.83 | 0.46 | -5.49 |
| ROE (%) | 6.92 | 36.99 | 6.82 | -116.31 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 0.79 | 4.35 | 0.51 | -6.30 |
| Debt to Equity | 5.37 | 5.68 | 8.96 | 14.74 |
The market Capitalisation of Arvee Laboratories (India) IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Arvee Laboratories (India) IPO prospectus highlights an Return on Equity (ROE) of 6.92 % , Return on Assets (ROA) of 0.79 %, and an EBITDA Margin of 15.89 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Arvee Laboratories (India) IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Arvee Laboratories (India) IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Arvee Laboratories (India) IPO has a Price-to-Earnings (PE) ratio of 52.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Arvee Laboratories (India) IPO reported revenue of ₹ 39.60 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Arvee Laboratories (India) IPO provide insights into sales growth, market demand, and business scalability.
Arvee Laboratories (India) recorded an EBITDA of ₹ 6.24 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Arvee Laboratories (India) Profit After Tax (PAT) is ₹ 0.62 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 39.28 Cr.
EBITDA Margin:
15.89
%
Net Worth: ₹ 4.48 Cr.
Market Capitalisation:
[●]
P/E:
52.00 times
P/BV: [●]
EV/EBITDA: [●]
Arvee Laboratories (India) operates in Chemical - Speciality and Specialty Chemicals. The Issue is listed on NSE EMERGE in Feb, 2018. Arvee Laboratories (India) IPO size was 8.91 with Issue price of 61.00 .
Merchant Banker(s) of Arvee Laboratories (India) IPO: Sarthi Capital Advisors Private Limited
Arvee Laboratories (India) IPO subscription was 2.90 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Arvee Laboratories (India) IPO listed at a listing price of 62.50 against the offer price of 61.00.
The current market price of Arvee Laboratories (India) is 161.17.
Why Us?
